Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

ClinicalTrials.gov ID: NCT07746687

Public ClinicalTrials.gov record NCT07746687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 2:55 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Trial to Evaluate the Efficacy and Safety of JNJ-95597528 for the Treatment of Adult Participants With Inadequately Controlled Moderate to Severe Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess how well JNJ-95597528 works when compared to placebo in adult participants with moderate to severe asthma (long-term condition that affects the airways in your lungs).

Study identification

NCT ID
NCT07746687
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Enrollment
440 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 5, 2026 (Actual)
Primary completion
Sep 11, 2029 (Estimated)
Completion
Jul 1, 2030 (Estimated)
Last update posted
Nov 3, 2026

2026 – 2030

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Allianz Research Institute, Inc. Westminster California 92683 Recruiting
Boston Specialists Boston Massachusetts 02111 Recruiting
Clinical Research Institute Minneapolis Minnesota 55402 Recruiting
Midwest Clinical Research LLC St Louis Missouri 63141 Recruiting
Equity Medical The Bronx New York 10455 Recruiting
OK Clinical Research Edmond Oklahoma 73034 Recruiting
Allergy Asthma and Clinical Research Center Martha Tarpay MD Oklahoma Texas 73120 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07746687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07746687 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →